These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication. Schaer B, Kühne M, Reichlin T, Osswald S, Sticherling C. Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686 [Abstract] [Full Text] [Related]
3. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy. Debonnaire P, Katsanos S, Joyce E, VAN DEN Brink OV, Atsma DE, Schalij MJ, Bax JJ, Delgado V, Marsan NA. J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421 [Abstract] [Full Text] [Related]
4. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial. Tompkins CM, Kutyifa V, Arshad A, McNitt S, Polonsky B, Wang PJ, Moss AJ, Zareba W. J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699 [Abstract] [Full Text] [Related]
13. Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases? Furushima H, Chinushi M, Iijima K, Hasegawa K, Sato A, Izumi D, Watanabe H, Aizawa Y. Europace; 2012 May; 14(5):675-81. PubMed ID: 22158850 [Abstract] [Full Text] [Related]